GLP-1 for Teenagers: What Parents Need to Know Before Considering This Treatment

When the topic is obesity treatment for teenagers, many families find themselves overwhelmed by conflicting information. On one side, success stories in the media. On the other, medical terms that feel like they belong on another planet. The goal of this post is to share what is known with certainty about GLP-1 medications for young people, without alarmism, without exaggerated promises, and based on what medical science has established so far.

What GLP-1 Medications Are and Why They Reached Teenagers

GLP-1 medications, such as semaglutide and liraglutide, were originally developed for type 2 diabetes treatment. What caught researchers' attention over the years was a side effect that was not really a side effect: significant appetite reduction. GLP-1 is a hormone the intestine produces naturally after a person eats. It signals the brain that hunger is under control, slows stomach emptying, and helps regulate insulin and blood sugar levels.

Over time, studies showed that this same mechanism could help people with obesity reduce food intake in a sustainable way. That is when the expansion to other age groups began.

In December 2022, the FDA approved the use of semaglutide at a dose of 2.4 mg weekly for adolescents 12 years and older with obesity. In Brazil, ANVISA already has registrations that allow pediatric use of liraglutide starting at age 12 in specific situations. A relevant study in this context is STEP TEEN, published in the New England Journal of Medicine in 2022, which followed young people over 68 weeks and observed an average reduction of 16% in BMI.

It is essential to understand what these medications are not. They are not weight loss shortcuts. They are not magic solutions. They are medical tools that work when they are part of a complete treatment plan, with guidance from a health care team and lifestyle changes.

When a Doctor Actually Recommends GLP-1 for a Teenager

Not every teenager who wants to lose a few pounds fits this treatment profile. Medical indication happens in a fairly specific way.

The first criterion is clinical obesity, defined as BMI above the 95th percentile for age and sex, according to WHO growth charts. But having that number alone is not enough. The second criterion is the presence of related complications, such as high blood pressure, insulin resistance, sleep apnea, or orthopedic problems. In some cases, teenagers with extremely high BMI, above the 99th percentile, may also be considered even without existing complications.

The health care professional also evaluates whether the teenager has enough emotional maturity to handle an injection routine and the most common side effects. In many scenarios, the first line of approach continues to be dietary changes and increased physical activity, always with multidisciplinary support.

When treatment is indicated, the recommended team usually includes a pediatrician, endocrinologist, nutritionist, and, when needed, a psychologist. The decision is never made by a single professional and involves an extensive conversation with the family.

How These Medications Work in a Teenager's Body

A frequent question among parents is about the difference between an appetite suppressant and a fat burner. GLP-1 does not burn fat directly. It adjusts the satiety signaling that had been working in overdrive.

In practice, the teenager still eats enough to grow and develop. The difference lies in the excessive hunger many young people with obesity experience, which operates as a difficult cycle to break. With GLP-1, that cycle is interrupted pharmacologically, and the young person can make food choices with less interference from uncontrolled appetite.

A teenager's body is still developing, with puberty phases, growth spurts, and nutritional needs that vary widely. That is why each case is assessed individually. Medical monitoring during this period takes these factors into account and adjusts the dose and treatment duration based on how the body responds.

Research shows that the average treatment time ranges from about 16 to 68 weeks, with continuous monitoring. Reduced appetite does not mean reduced essential nutrients when eating is guided by a nutritionist. Ozempro can be a useful tool in this process, offering daily meal tracking and hydration reminders that make the routine more practical and less dependent on remembering every choice.

Side Effects: What to Expect and What Is Not Normal

Transparency about side effects is an important part of the family decision. There is no point in hiding information that could cause alarm later.

The most frequent effects are gastrointestinal. Nausea, vomiting, diarrhea, or constipation may appear, especially in the first few weeks, while the body is still adjusting. Generally, these symptoms improve over time and with dose adjustments directed by the doctor. Study data shows that nausea occurs in up to 30% of patients in the first months, but it usually resolves.

What requires immediate attention are less common signs, such as severe abdominal pain, persistent vomiting, or symptoms of serious hypoglycemia. Rarely, there have been reports of severe abdominal pain that required investigation for pancreatitis. The medication is also contraindicated in cases of personal or family history of medullary thyroid cancer.

There is also an important consideration around mental health. Some patients reported depressive symptoms or self-harm thoughts during treatment. That is why psychological monitoring is not optional during GLP-1 use in teenagers. It allows for early identification of warning signs and appropriate support.

The Role of Eating and Exercise During Treatment

A common question is: if my child is taking the medication, does he or she still need to pay attention to food? The answer is yes, and in a different way than many people imagine.

The goal is not restrictive dieting, because that can compromise a teenager's growth and development. The focus is on quality. Enough protein for muscle and bone formation, fewer ultra-processed foods, and physical activity that the young person actually enjoys doing.

For active teenagers, the protein recommendation falls around 1.2 to 1.6 grams per kilogram of body weight per day. Strength training is especially important during weight loss, because it helps preserve muscle mass that would otherwise be lost.

Quarterly nutritional follow-up is sufficient in most cases, as long as there is consistency in medical monitoring. Ozempro offers features that support this routine, with meal logging and reminders that make day-to-day life more organized, without pressure or judgment.

How Long Does a Teenager Stay on the Medication

When treatment starts working, an inevitable question comes up: does my child need to take this forever?

The answer depends on each case. Research shows that many people regain part of the lost weight when they stop the medication abruptly, because appetite mechanisms return to their pre-treatment state. In the STEP 1 study, conducted with adults, about two-thirds of the lost weight was regained within one year after discontinuation.

That is why the decision to maintain, reduce, or stop the dose must be made together with the doctor, never abruptly. Gradual tapering is preferable to stopping all at once.

The real goal of treatment is for the teenager to develop sustainable habits during the time they are on the medication. Those habits are what will sustain the results long term. Treatment duration can range from months to years, depending on the initial situation and individual response. There is no rush in this process, and each step needs to be discussed openly with the family and health care team.

Emotional Support and Mental Health Throughout the Process

Teenagers with obesity often carry more than just extra weight. Many have experienced bullying, have affected self-esteem, deal with anxiety, or show signs of depression. Not recognizing this means ignoring a fundamental part of the problem.

When treatment works and the young person starts feeling in control, many of these aspects improve. But frustration can also set in if expectations were unrealistic from the start. Psychological monitoring is not an optional addition. It is an essential part of treatment, alongside medication and nutrition.

Data from the American Academy of Pediatrics indicates that teenagers with obesity face an approximately 30% higher risk of developing depression. Recent studies also suggest that GLP-1 use may reduce anxiety symptoms in some patients, although more research is needed to fully understand this relationship.

Cognitive behavioral therapy sessions, when combined with pharmacological treatment, show positive outcomes. Family support and a supportive school environment also make a tremendous difference: creating a space that encourages change without pressure or judgment makes the whole process much easier.

Ozempro can be a partner on this journey, allowing the teenager to track their progress in a simple, judgment-free way, which helps build a healthier relationship with their own body and with everyday choices. You can learn more about how the app supports this process by clicking here.